Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Stem cells can repair parkinson's-damaged circuits in mouse brains

Stem cells can repair parkinson's-damaged circuits in mouse brains

Researchers identify new therapeutic target for spinocerebellar ataxia

Researchers identify new therapeutic target for spinocerebellar ataxia

Biomarker for diagnosis of neurodegenerative diseases identified in the eye

Biomarker for diagnosis of neurodegenerative diseases identified in the eye

Star-shaped brain cells are essential for blood-brain barrier health, shows study

Star-shaped brain cells are essential for blood-brain barrier health, shows study

Smart drug delivery system may help treat spinal cord injuries and other neurological disorders

Smart drug delivery system may help treat spinal cord injuries and other neurological disorders

Researchers identify the cause for Parkinson's disease and potential treatments

Researchers identify the cause for Parkinson's disease and potential treatments

Researchers explore link between uncontrolled inflammation and brain's immune cells

Researchers explore link between uncontrolled inflammation and brain's immune cells

Study highlights the role of brain astrocyte cells in Parkinson's disease pathology

Study highlights the role of brain astrocyte cells in Parkinson's disease pathology

Researchers perform massive and detailed cellular energy audit

Researchers perform massive and detailed cellular energy audit

Findings show new promise for using stem cells to treat enteric nervous system disorders

Findings show new promise for using stem cells to treat enteric nervous system disorders

Protective anti-prion antibodies found in humans

Protective anti-prion antibodies found in humans

Switching off 'master regulator' may offer neuroprotection from Parkinson's-related damage

Switching off 'master regulator' may offer neuroprotection from Parkinson's-related damage

Mathematical model shows how stability inherently arises in the brain

Mathematical model shows how stability inherently arises in the brain

Rutgers expert highlights the effects of climate change on allergies, autoimmunity and the microbiome

Rutgers expert highlights the effects of climate change on allergies, autoimmunity and the microbiome

Machine learning can increase effectiveness of drug repurposing for psychiatric disorders

Machine learning can increase effectiveness of drug repurposing for psychiatric disorders

Research identifies how the gut communicates with spinal cord and brain

Research identifies how the gut communicates with spinal cord and brain

Study sheds light on the role of white blood cells in the developing brain

Study sheds light on the role of white blood cells in the developing brain

Study: High levels of iron in the blood can prevent age-related damage

Study: High levels of iron in the blood can prevent age-related damage

Study: PINK1 and Parkin work together to induce selective autophagy

Study: PINK1 and Parkin work together to induce selective autophagy

Salmonella biofilm protein can cause autoimmunity and arthritis in animals

Salmonella biofilm protein can cause autoimmunity and arthritis in animals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.